Relative short-term efficacy and acceptability of agomelatine versus vortioxetine in adult patients suffering from major depressive disorder

被引：0

作者：

Kennedy, S. ^{[1
]}

Grouin, J. ^{[2
]}

Cadour, S. ^{[3
]}

Robert, V. ^{[3
]}

Picarel-Blanchot, F. ^{[4
]}

机构：

[1] Univ Toronto, Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada

[2] Univ Rouen, INSERM, U1219, Populat Hlth, Rouen, France

[3] IRIS, Biostat Dept, Suresnes, France

[4] IRIS, Neuropsychiat Innovat Therapeut Pole, Suresnes, France

来源：

EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2016年 / 26卷

关键词：

METAANALYSIS;

D O I：

10.1016/S0924-977X(16)31450-X

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P.2.f.007

引用

页码：S457 / S458

页数：2

共 50 条

[21] EFFICACY OF THE ANTIDEPRESSANT AGOMELATINE FOR THE ANXIETY SYMPTOMS OF DEPRESSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
Stein, D. J.
Castle, D. J.
Kennedy, S. H.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2012, 46 : 31 - 32
[22] Efficacy and safety of desvenlafaxine succinate in the short-term treatment of major depressive disorder in adults
Septien-Velez, L.
Pitrosky, B.
Padmanabhan, S. K.
Germain, J. M.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S234 - S234
[23] COST-UTILITY ANALYSIS EVALUATING VORTIOXETINE VERSUS VENLAFAXINE XR AND AGOMELATINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN TAIWAN
Brignone, M.
Atsou, K.
Reynaud-Mougin, C.
Chen, W.
Milea, D.
VALUE IN HEALTH, 2016, 19 (07) : A841 - A842
[24] Effectiveness of long-term vortioxetine treatment of patients with major depressive disorder
Vieta, Eduard
Loft, Henrik
Florea, Ioana
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 (09) : 877 - 884
[25] RELATIVE EFFICACY AND TOLERABILITY OF VORTIOXETINE COMPARED WITH SELECTED ANTIDEPRESSANTS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER WITH AN INADEQUATE RESPONSE TO PRIOR THERAPY
Diamand, F.
Painchault, C.
Brignone, M.
VALUE IN HEALTH, 2015, 18 (03) : A116 - A116
[26] The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram
Vieta, Eduard
Sluth, Lasse B.
Olsen, Christina K.
JOURNAL OF AFFECTIVE DISORDERS, 2018, 227 : 803 - 809
[27] Long-term efficacy of agomelatine, a novel antidepressant, in the prevention of relapse in out-patients with major depressive disorder
Goodwin, G. M.
Rouillon, F.
Emsley, R.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S361 - S362
[28] Prevalence Of Major Depressive Disorder In Patients Suffering From Tuberculosis
Thakrar, Pooja Nalinchandra
Garg, Aditi
Oswal, Rajat
INDIAN JOURNAL OF PSYCHIATRY, 2017, 59 (06) : S175 - S175
[29] A DESCRIPTIVE STUDY OF PATIENTS SUFFERING FROM MAJOR DEPRESSIVE DISORDER
Pereira, Crissen Kennedy
INDIAN JOURNAL OF PSYCHIATRY, 2020, 62 : S24 - S24
[30] Effect of agomelatine on circadian rhythms in outpatients suffering from major depressive disorder over 6 weeks
Hajak, G.
Landowski, J.
Marx, U.
Olivier, V.
Picarel-Blanchot, F.
De Bodinat, C.
Kasper, S.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S849 - S849

← 1 2 3 4 5 →